Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 8, Issue 22

November 26 2024

In Progress

In this Issue

GENE THERAPY
CLINICAL TRIALS AND OBSERVATIONS
THROMBOSIS AND HEMOSTASIS
Red Cells, Iron, and Erythropoiesis
ERRATUM

GENE THERAPY

Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice

Vincenzo La Mura,Vincenzo Cardinale,Raimondo De Cristofaro,Adriano De Santis,Giovanni Di Minno,Luca Fabris,Fabio Marra,Filomena Morisco,Flora Peyvandi,Maurizio Pompili,Cristina Santoro,Ezio Zanon,Giancarlo Castaman

View Articletitled, Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice

CLINICAL TRIALS AND OBSERVATIONS

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis
Clinical Trials & Observations

Chenyu Lin,Anand A. Patel,Dezheng Huo,Theodore Karrison,Koen van Besien,John Godwin,Dorie Sher,Howie Weiner,Margaret Green,James L. Wade, III,Rebecca Klisovic,Maria R. Baer,Richard A. Larson,Wendy Stock,Olatoyosi Odenike

View Articletitled, A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis

Supplemental data

THROMBOSIS AND HEMOSTASIS

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Halina H. L. Leung,Zohra Ahmadi,Brendan Lee,John Casey,Sumita Ratnasingam,Steven E. McKenzie,Jose Perdomo,Beng H. Chong

View Articletitled, Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Supplemental data

Red Cells, Iron, and Erythropoiesis

In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbb^th3/+) mice

Yang Yu,Regina R. Woloshun,Jennifer K. Lee,Pearl O. Ebea-Ugwuanyi,Jacob S. Shine,Sean Zhu,Yue He,James F. Collins

View Articletitled, In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbbth3/+) mice

Supplemental data

ERRATUM

Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.

View Articletitled, Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.

All Issues

Advertisement intended for health care professionals

Email alerts

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read
Most Cited

Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis

In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbb^th3/+) mice

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Advertisement intended for health care professionals

GENE THERAPY

Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice

CLINICAL TRIALS AND OBSERVATIONS

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis
Clinical Trials & Observations

THROMBOSIS AND HEMOSTASIS

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Red Cells, Iron, and Erythropoiesis

In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbb^th3/+) mice

ERRATUM

Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

GENE THERAPY

Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice

CLINICAL TRIALS AND OBSERVATIONS

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis Clinical Trials & Observations

THROMBOSIS AND HEMOSTASIS

Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Red Cells, Iron, and Erythropoiesis

In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbbth3/+) mice

ERRATUM

Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis
Clinical Trials & Observations

In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbb^th3/+) mice